| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.79B | 48.58B | 44.26B | 43.32B | 41.88B | 41.20B |
| Gross Profit | 17.10B | 18.91B | 16.87B | 16.50B | 17.50B | 15.96B |
| EBITDA | 6.08B | 7.89B | 6.35B | 5.64B | 8.09B | 6.95B |
| Net Income | 2.29B | 3.18B | 2.48B | 2.22B | 3.25B | 3.12B |
Balance Sheet | ||||||
| Total Assets | 87.48B | 79.86B | 81.16B | 72.05B | 66.45B | 62.61B |
| Cash, Cash Equivalents and Short-Term Investments | 11.66B | 10.77B | 12.96B | 10.49B | 11.45B | 9.45B |
| Total Debt | 9.46B | 8.79B | 9.81B | 11.08B | 7.02B | 8.19B |
| Total Liabilities | 23.81B | 21.32B | 23.71B | 22.15B | 18.53B | 18.95B |
| Stockholders Equity | 52.45B | 48.60B | 47.73B | 42.84B | 41.42B | 38.68B |
Cash Flow | ||||||
| Free Cash Flow | 549.00M | 248.00M | 2.99B | -2.06B | 4.38B | 3.07B |
| Operating Cash Flow | 6.12B | 5.67B | 8.34B | 1.06B | 6.14B | 5.38B |
| Investing Cash Flow | -4.51B | -6.55B | -3.95B | -7.04B | -3.57B | -2.69B |
| Financing Cash Flow | -685.00M | -1.88B | -2.07B | 2.29B | -1.85B | -424.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥36.08B | 9.56 | ― | 1.90% | 2.15% | 16.14% | |
75 Outperform | ¥56.27B | 16.36 | ― | 2.92% | 3.03% | 28.27% | |
74 Outperform | ¥36.55B | 15.61 | ― | 3.70% | 14.83% | 51.42% | |
70 Outperform | ¥57.87B | -468.17 | ― | 4.37% | -1.09% | ― | |
67 Neutral | ¥37.79B | 11.77 | ― | 2.37% | -11.70% | -54.82% | |
66 Neutral | ¥34.86B | 35.78 | ― | 3.24% | 1.83% | -8.54% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |